Literature DB >> 21336824

Reproducibility of oxygen saturation monitoring during six-minute walk test and exercise stress test in patients with pulmonary arteriovenous malformations associated with hereditary hemorrhagic telangiectasia.

Walter Li1, Bolin Niu, Katherine Henderson, Veronika Northrup, Jeffery S Pollak, Terence Trow, John Fahey, Robert I White.   

Abstract

Patients with pulmonary arteriovenous malformations (PAVMs) are at risk for multiple complications and require close follow-up. We investigated the reproducibility of the 6-minute walk test (6MWT) and exercise stress test (EST) for the evaluation of low oxygen saturation in patients with PAVMs. Twenty-two patients with PAVMs, most of whom had hereditary hemorrhagic telangiectasia (HHT), participated in a Human Investigations Committee-approved protocol. Patients ranged from 9 to 74 years of age (mean 28) and had a broad spectrum of anatomic subtypes of PAVMs, including focal and diffuse. Standard 6MWT and cycle ergometry EST were both performed twice with adequate rest between tests. Heart rate (HR) and oxygen saturation were measured at the beginning and end of each test. Distance walked and maximum resistance was also recorded. The intraclass correlation coefficients (r(i)) at the end of 6MWT were as follows: HR (r(i) = 0.940; 95% confidence interval [CI] 0.863-0.975), oxygen saturation (r(i) = 0.973; 95% CI 0.933-0.989), and distance (r(i) = 0.942; 95% CI 0.867-0.975). The r(i)s at the end of EST were as follows: HR (r(i) = 0.941; 95% CI 0.865-0.975), oxygen saturation (r(i) = 0.993; 95% CI 0.982-0.997), and maximum resistance (r(i) = 0.941; 95% CI 0.864-0.975). 6MWT and EST were reproducible measures of exercise capacity and oxygen saturation and are potential adjunct tests in the follow-up assessment for patients with PAVMs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21336824     DOI: 10.1007/s00246-011-9917-8

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  20 in total

Review 1.  Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms.

Authors:  C L Shovlin; M Letarte
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

2.  ATS statement: guidelines for the six-minute walk test.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-07-01       Impact factor: 21.405

3.  Pulmonary arteriovenous malformation treated with embolotherapy: systemic collateral supply at multidetector CT angiography after 2-20-year follow-up.

Authors:  Pierre-Yves Brillet; Philippe Dumont; Nébil Bouaziz; Alain Duhamel; François Laurent; Jacques Remy; Martine Remy-Jardin
Journal:  Radiology       Date:  2006-11-20       Impact factor: 11.105

Review 4.  Computed tomography--an increasing source of radiation exposure.

Authors:  David J Brenner; Eric J Hall
Journal:  N Engl J Med       Date:  2007-11-29       Impact factor: 91.245

5.  2010 ACR Presidential Address: Patient-focused radiology: taking charge of radiation dose.

Authors:  Carol M Rumack
Journal:  J Am Coll Radiol       Date:  2010-11       Impact factor: 5.532

6.  Clinical and anatomic outcomes after embolotherapy of pulmonary arteriovenous malformations.

Authors:  Jeffrey S Pollak; Sanjay Saluja; Ashraf Thabet; Katharine J Henderson; Neil Denbow; Robert I White
Journal:  J Vasc Interv Radiol       Date:  2006-01       Impact factor: 3.464

7.  Pulmonary arteriovenous fistulas: Mayo Clinic experience, 1982-1997.

Authors:  K L Swanson; U B Prakash; A W Stanson
Journal:  Mayo Clin Proc       Date:  1999-07       Impact factor: 7.616

8.  Pulmonary arteriovenous malformations: cerebral ischemia and neurologic manifestations.

Authors:  M Moussouttas; P Fayad; M Rosenblatt; M Hashimoto; J Pollak; K Henderson; T Y Ma; R I White
Journal:  Neurology       Date:  2000-10-10       Impact factor: 9.910

9.  Pulmonary arteriovenous malformations: techniques and long-term outcome of embolotherapy.

Authors:  R I White; A Lynch-Nyhan; P Terry; P C Buescher; E J Farmlett; L Charnas; K Shuman; W Kim; M Kinnison; S E Mitchell
Journal:  Radiology       Date:  1988-12       Impact factor: 11.105

10.  Life-threatening pulmonary hemorrhage with pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasia.

Authors:  B A Ference; T M Shannon; R I White; M Zawin; C M Burdge
Journal:  Chest       Date:  1994-11       Impact factor: 9.410

View more
  2 in total

Review 1.  Pulmonary arteriovenous malformations.

Authors:  Claire L Shovlin
Journal:  Am J Respir Crit Care Med       Date:  2014-12-01       Impact factor: 21.405

2.  Pulmonary arteriovenous malformations: haemodynamics and shunt closure.

Authors:  D Merkus
Journal:  Neth Heart J       Date:  2014-08       Impact factor: 2.380

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.